Recommended Starting Dose for Ozempic in Weight Management
Ozempic (semaglutide) starts at 0.25 mg injected subcutaneously once weekly for the first 4 weeks when used for weight management. This low initial dose minimizes gastrointestinal side effects like nausea. After 4 weeks, the dose increases to 0.5 mg weekly, with further titration to 1 mg, 1.7 mg, or 2 mg based on response and tolerance.
How Dosing Progresses for Weight Loss
- Weeks 1-4: 0.25 mg (starting dose).
- Weeks 5+: 0.5 mg.
- Optional escalation: Up to 1 mg (week 9+), 1.7 mg (week 17+), or 2 mg (week 25+), per clinical guidelines.
Dosing follows the same schedule as for type 2 diabetes, as Ozempic is FDA-approved only for diabetes but commonly prescribed off-label for weight loss. Maximum dose is 2 mg weekly.
Why Start Low and What If Side Effects Occur
The 0.25 mg start allows the body to adjust, reducing nausea, vomiting, or diarrhea—common in 20-40% of patients early on. If side effects persist, doctors may pause titration or revert to a lower dose. Always follow a healthcare provider's plan; self-adjusting risks inefficacy or complications.
Differences from Wegovy (Pure Weight Loss Version)
Wegovy, also semaglutide, uses identical titration (0.25 mg start) but goes up to 2.4 mg weekly for obesity. Ozempic caps at 2 mg. Both pens differ: Ozempic pens deliver 0.25/0.5 mg, 1 mg, or 2 mg doses; Wegovy has multi-dose options.
Who Should Avoid or Adjust This Dose
Not for type 1 diabetes, pancreatitis history, or thyroid cancer risk. Kidney/liver issues may need lower starts. Pregnant or breastfeeding patients should not use it. Consult a doctor for personalized dosing.
Sources:
[1] Ozempic Prescribing Information (Novo Nordisk)
[2] FDA Label for Ozempic
[3] Wegovy Prescribing Information (Novo Nordisk)